You are here

News and Events

For an overview of the latest news, press releases and blog posts from Cancer Research UK visit the Cancer News page.

Below you will find the latest press releases, news and event information from the Cancer Research UK Commercial Partnerships team and our legal entity, Cancer Research Technology (CRT).

Date1	Press Release
23 March 2015	FORMA Therapeutics and CRT form two virtual companies to advance deubiquitination assets	Read more
20 January 2015	Valneva and BliNK Therapeutics confirm launch and funding of BliNK Biomedical	Read more
20 January 2015	BioInvent’s BI-1206 antibody to enter collaborative Phase I/II trial funded and conducted by Cancer Research UK, CRT and Leukaemia & Lymphoma Research	Read more
22 December 2014	Cancer Research UK, CRT and Amgen to trial leukaemia immunotherapy drug in other cancers	Read more
16 December 2014	CRT Pioneer Fund banks £20m investment from BACIT and expands agreement with Chroma Therapeutics to develop cancer immunotherapies	Read more
10 December 2014	Three new companies join Cancer Research UK-Abcodia collaboration to identify blood markers for early cancer detection	Read more
28 November 2014	Cancer Research UK to collaborate with AstraZeneca in screening for new cancer medicines at the AstraZeneca MRC UK Centre for Lead Discovery	Read more
26 November 2014	BACIT seeks shareholder approval to commit £20m and join CRT Pioneer Fund as a limited partner	Read more
21 November 2014	£50M CRT Pioneer Fund announces investment to develop lung cancer drugs at Cancer Research UK's Manchester Institute	Read more
27 October 2014	Cancer Research UK and Leukaemia & Lymphoma Research team up to boost blood cancer trials	Read more

Pages

Date	Other news
23 November 2010	We are moving
23 November 2010	CRT drives novel and collaborative drug discovery in areas of "hot" cancer science
23 November 2010	Maximising our global network
6 November 2010	Temodar® patent enforcement case won
18 June 2010	Oxford BioMedica announces amendment to 5T4 licence agreement with CRT and issue of shares
29 April 2010	CRT Discovery Laboratories team up with industry
29 April 2010	There's more to CRT than drug discovery and development
29 April 2010	'Science & Seafood' - A new format networking event for the science community
15 March 2010	Vernalis achieves $3m milestone payment on Hsp90 Inhibitor collaboration with Novartis
10 March 2010	Transgene signs an exclusive option with Novartis for MUC1 product from CRT.

Pages